Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN108498 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Tumor Necrosis Factor Receptor Superfamily, Member 11b (TNFRSF11B) antibody
- Antibody type
- Monoclonal
- Antigen
- Other
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- OPG-01
- Vial size
- 0.1 mg
- Storage
- Store lyophilized antibody at 2-8°C. Aliquot the product after reconstitution to avoid repeated freezing/thawing cycles and store frozen at -80°C. Reconstituted antibody can be stored at 4°C for a limited period of time, it does not show decline in activity after two weeks at 4°C.
Submitted references Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification.
Serum osteoprotegerin but not receptor activator of NF-kappaB ligand correlates with Larsen score in rheumatoid arthritis.
IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology.
Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Kaden JJ, Bickelhaupt S, Grobholz R, Haase KK, Sarikoç A, Kiliç R, Brueckmann M, Lang S, Zahn I, Vahl C, Hagl S, Dempfle CE, Borggrefe M
Journal of molecular and cellular cardiology 2004 Jan;36(1):57-66
Journal of molecular and cellular cardiology 2004 Jan;36(1):57-66
Serum osteoprotegerin but not receptor activator of NF-kappaB ligand correlates with Larsen score in rheumatoid arthritis.
Skoumal M, Kolarz G, Woloszczuk W, Hawa G, Klingler A
Annals of the rheumatic diseases 2004 Feb;63(2):216-7
Annals of the rheumatic diseases 2004 Feb;63(2):216-7
IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology.
Kwan Tat S, Padrines M, Théoleyre S, Heymann D, Fortun Y
Cytokine & growth factor reviews 2004 Feb;15(1):49-60
Cytokine & growth factor reviews 2004 Feb;15(1):49-60
Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.
Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K
Endocrinology 1998 Mar;139(3):1329-37
Endocrinology 1998 Mar;139(3):1329-37
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ
Cell 1997 Apr 18;89(2):309-19
Cell 1997 Apr 18;89(2):309-19
No comments: Submit comment
No validations: Submit validation data